Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “AstraZeneca”

Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCLActive Not Recruiting
NCT03863184Phase 2Updated Apr 28, 2026
Sponsor: Weill Medical College of Cornell University
Mantle Cell Lymphoma
United States
Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation ProcedureActive Not Recruiting
NCT06045975Phase 2Updated Apr 24, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
HCC - Hepatocellular Carcinoma
France
Structured Review: To Optimise Management and Prevent Harm in COPDRecruiting
NCT07460154NAUpdated Apr 23, 2026
Sponsor: Northumbria Healthcare NHS Foundation Trust
COPD
United Kingdom
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsActive Not Recruiting
NCT03682289Phase 2Updated Apr 23, 2026
Sponsor: Rahul Aggarwal
Clear Cell Renal Cell Carcinoma · Locally Advanced Pancreatic Cancer · Locally Advanced Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm
United States
Acalabrutinib Real World Italian obSErvational Study -ARISEActive Not Recruiting
NCT06205498N/AUpdated Apr 23, 2026
Sponsor: AstraZeneca
Chronic Lymphocytic Leukemia
Italy
Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior OsimertinibActive Not Recruiting
NCT03778229Phase 2Updated Apr 23, 2026
Sponsor: AstraZeneca
Carcinoma
United States, Brazil, Canada, Chile, Denmark +8 more
Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the ThoraxActive Not Recruiting
NCT05617963Phase 2Updated Apr 23, 2026
Sponsor: UNICANCER
Small Cell Lung Carcinoma
France
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With AsthmaRecruiting
NCT07525375Phase 2Updated Apr 22, 2026
Sponsor: AstraZeneca
Asthma
United States, Argentina, Czechia, Hungary, Mexico +2 more
PREDICT-RD: ctDNA Surveillance in TNBC With Residual DiseaseRecruiting
NCT07069595Phase 2Updated Apr 22, 2026
Sponsor: UNC Lineberger Comprehensive Cancer Center
Breast Cancer · Residual Disease · Triple Negative Breast Cancer (TNBC) · Stage II/III
United States
Enhanced COPD Management in Suspected Lung Cancer PatientsRecruiting
NCT07543601NAUpdated Apr 22, 2026
Sponsor: Ditte Krag-Hansen
COPD (Chronic Obstructive Pulmonary Disease) · Lung Cancer (Diagnosis) · Lung Neoplasm Malignant · Lung Carcinoma
Denmark
A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes MellitusSuspended
NCT07433062Phase 1Updated Apr 22, 2026
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
Germany
Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus ErythematosusCompleted
NCT06485674N/AUpdated Apr 22, 2026
Sponsor: AstraZeneca
Long-Term Organ Damage in Adult Patients With Active Systemic Lupus Erythematosus
Canada
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic AlterationsActive Not Recruiting
NCT05687266Phase 3Updated Apr 22, 2026
Sponsor: AstraZeneca
NSCLC
United States, Austria, Brazil, Bulgaria, Canada +18 more
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 MutationsActive Not Recruiting
NCT05457257Phase 4Updated Apr 21, 2026
Sponsor: AstraZeneca
Metastatic Castration-resistant Prostate Cancer
China
AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerCompleted
NCT02296125Phase 3Updated Apr 21, 2026
Sponsor: AstraZeneca
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
United States, Australia, Belgium, Brazil, Bulgaria +25 more
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant HypertensionCompleted
NCT06344104Phase 3Updated Apr 21, 2026
Sponsor: AstraZeneca
Uncontrolled Hypertension · Resistant Hypertension
Argentina, Australia, China, Hong Kong, India +6 more
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal JunctionActive Not Recruiting
NCT05480384Phase 2Updated Apr 21, 2026
Sponsor: Brown University
Esophageal Adenocarcinoma · Esophageal Cancer · HER-2 Protein Overexpression · Gastroesophageal-junction Cancer
United States
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell MalignanciesActive Not Recruiting
NCT03932331Phase 1, Phase 2Updated Apr 20, 2026
Sponsor: AstraZeneca
Phase I: Relapsed or Refractory B-cell Malignancies · Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma · Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic Leukemia
China
Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry StudyRecruiting
NCT06521229N/AUpdated Apr 20, 2026
Sponsor: AstraZeneca
Uncontrolled Asthma
Russia
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast CancerActive Not Recruiting
NCT03820141Phase 2Updated Apr 20, 2026
Sponsor: The Methodist Hospital Research Institute
Breast Cancer
United States
AZD9291 First Time In Patients Ascending Dose StudyCompleted
NCT01802632Phase 1, Phase 2Updated Apr 20, 2026
Sponsor: AstraZeneca
Advanced Non Small Cell Lung Cancer · Advanced (Inoperable) Non Small Cell Lung Cancer
United States, Australia, France, Germany, Italy +5 more
Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic CancerCompleted
NCT04128332NAUpdated Apr 20, 2026
Sponsor: CCTU- Cancer Theme
Cancer of Pancreas
United Kingdom
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)Enrolling By Invitation
NCT05667493Phase 3Updated Apr 17, 2026
Sponsor: Ionis Pharmaceuticals, Inc.
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
United States, Argentina, Australia, Austria, Belgium +15 more
Cancer in Patients on Dapagliflozin and Other Antidiabetic TreatmentCompleted
NCT02695121N/AUpdated Apr 17, 2026
Sponsor: AstraZeneca
Breast Cancer · Bladder Cancer
United States, Netherlands, United Kingdom
Retrospective Study on Characteristics and Outcomes in Hospitalised Patients Treated With OndexxyaCompleted
NCT05898412N/AUpdated Apr 17, 2026
Sponsor: AstraZeneca
Hemorrhage
Netherlands

Previous page Next page